Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature

Timed sequential therapy (TST) aims to improve outcomes in acute myelogenous leukemia (AML) by harnessing drug-induced cell cycle kinetics of AML, where a second drug is timed to coincide with peak leukemia proliferation induced by the first drugs. We analyzed outcomes in 301 newly diagnosed AML pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Res
Main Authors: Norsworthy, Kelly J., DeZern, Amy E., Tsai, Hua-Ling, Hand, Wesley A., Varadhan, Ravi, Gore, Steven D., Gojo, Ivana, Pratz, Keith, Carraway, Hetty E., Showel, Margaret, McDevitt, Michael A., Gladstone, Douglas, Ghiaur, Gabriel, Prince, Gabrielle, Seung, Amy H., Benani, Dina, Levis, Mark J., Karp, Judith E., Smith, B. Douglas
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813685/
https://ncbi.nlm.nih.gov/pubmed/28869816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2017.08.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares